VFA
AGIO icon

Virtus Fund Advisers’s Agios Pharmaceuticals AGIO Stock Holding History

Virtus Fund Advisers’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$379K Buy
+6,624
New +$417K ﹤0.01% 374
2014
Q3 		– Sell
-1,158
Closed -$53K – 1170
2014
Q2 		$53K Buy
+1,158
New +$47.2K ﹤0.01% 1817

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Virtus Fund Advisers's AGIO Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Agios Pharmaceuticals (AGIO) in Q4 2017: 6,624 shares worth $379K. The stake represents ﹤0.01% of the portfolio and ranks #374 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in AGIO as recently as Q2 2014.

Virtus Fund Advisers first reported a position in AGIO in Q2 2014 and has held it in 2 quarters since. 178 funds tracked by Wall St. Rank hold AGIO as of Q4 2017.

  • Virtus Fund Advisers held 6,624 shares of Agios Pharmaceuticals worth $379K as of Q4 2017.
  • Agios Pharmaceuticals was a new Virtus Fund Advisers position in Q4 2017.
  • Agios Pharmaceuticals made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #374 holding.
  • Virtus Fund Advisers first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 2 quarters since.
  • 178 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.